FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

423799007: Product containing hydrochlorothiazide and olmesartan medoxomil (medicinal product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    3487257011 Product containing hydrochlorothiazide and olmesartan medoxomil (medicinal product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3495616012 Product containing hydrochlorothiazide and olmesartan medoxomil en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3668397012 Hydrochlorothiazide and olmesartan medoxomil product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    50015861000188111 médicament contenant olmésartan médoxomil et hydrochlorothiazide fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    médicament contenant olmésartan médoxomil et hydrochlorothiazide Is a Product containing olmesartan (medicinal product) false Inferred relationship Some
    médicament contenant olmésartan médoxomil et hydrochlorothiazide Is a Angiotensin II receptor antagonist+diuretic false Inferred relationship Some
    médicament contenant olmésartan médoxomil et hydrochlorothiazide Is a Product containing hydrochlorothiazide (medicinal product) false Inferred relationship Some
    médicament contenant olmésartan médoxomil et hydrochlorothiazide The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Olmesartan (substance) false Inferred relationship Some
    médicament contenant olmésartan médoxomil et hydrochlorothiazide The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Hydrochlorothiazide (substance) false Inferred relationship Some
    médicament contenant olmésartan médoxomil et hydrochlorothiazide The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Olmesartan medoxomil (substance) false Inferred relationship Some
    médicament contenant olmésartan médoxomil et hydrochlorothiazide Is a olmésartan médoxomil false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet Is a False médicament contenant olmésartan médoxomil et hydrochlorothiazide Inferred relationship Some
    Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet Is a False médicament contenant olmésartan médoxomil et hydrochlorothiazide Inferred relationship Some
    Product containing precisely hydrochlorothiazide 25 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) Is a False médicament contenant olmésartan médoxomil et hydrochlorothiazide Inferred relationship Some
    Product containing amlodipine and hydrochlorothiazide and olmesartan medoxomil Is a False médicament contenant olmésartan médoxomil et hydrochlorothiazide Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start